Delivery Order SPE2DB20D1109-SPE2DB25FP58B
- Not listed
- AmerisourceBergen Drug Corp was awarded a $5,560.53 delivery order by the Defense Logistics Agency for Prevnar 20 vaccine in syringe form (0.5mL), with an ultimate completion date of August 27, 2025. The contract was awarded on August 26, 2025, using firm fixed price terms with no set-aside designation. The place of performance is listed as Conshohocken, Pennsylvania, which serves as AmerisourceBergen's corporate headquarters and a primary distribution center for its pharmaceutical supply...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $3,267.56 by the Defense Logistics Agency (DLA) for the supply of Prevnar 20 vaccines in 0.5mL syringes. The contract is classified as a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The award was executed on August 28, 2025, with an ultimate completion date of August 29, 2025, and the product will be delivered to AmerisourceBergen's corporate office location in...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on May 8, 2025, valued at $21,820.23 for the supply of PREVNAR 20 vaccine in 0.5 mL syringes. This is a firm fixed price, competitively awarded contract with no set-aside designation and a completion date of May 9, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a relatively small transaction within...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $9,802.62 by the Defense Logistics Agency (DLA) on July 25, 2025, for the supply of Prevnar 20 Syringe 0.5ML, a pneumococcal vaccine. This is a firm fixed price, non-set-aside contract with an ultimate completion date of July 28, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract against AmerisourceBergen Drug Corp's larger Indefinite Delivery...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $3,267.56 by the Defense Logistics Agency on August 13, 2025, for the supply of Prevnar 20 vaccine in 0.5mL syringes. The contract utilizes firm fixed price terms with an ultimate completion date of August 14, 2025, and was competitively awarded without set-aside designation. This delivery order is issued under AmerisourceBergen's existing Indefinite...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $10,989.90 by the Defense Logistics Agency (DLA) on July 14, 2025. The order is for Prevnar 20 vaccine in 0.5ml syringes and will be completed by July 15, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and represents a child delivery order under AmerisourceBergen's broader Indefinite Delivery Contract...
- AmerisourceBergen Drug Corp was awarded a delivery order contract on September 10, 2025, by the Defense Logistics Agency's Medical Supply Chain to deliver PREVNAR 20 syringes (0.5ML) with a ceiling value of $30,254.25. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of September 11, 2025, and represents a non-set-aside competitive award. The place of performance is AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $32,370.91 by the Defense Logistics Agency on June 26, 2025, for the supply of PREVNAR 20 syringe (0.5mL) vaccine product. The contract employs firm fixed pricing and is set to be completed by June 27, 2025. This delivery order is non-competitive, indicating it was issued under an existing contract vehicle rather than through open solicitation. This award is issued as a child contract...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on April 22, 2025, for the supply of Prevnar 20 vaccine in 0.5 milliliter syringes. This firm fixed-price delivery order, valued at $10,289.11, is scheduled for completion by April 23, 2025, and represents a non-set-aside, competitively awarded contract. The award was executed as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $29,835.95 by the Defense Logistics Agency (DLA) on June 25, 2025, for the supply of Prevnar 20 vaccine in 0.5mL syringes. This is a firm fixed-price delivery order with an ultimate completion date of June 26, 2025, and represents a non-set-aside competitive award. The contract will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB25FP58BDelivery Order
AmerisourceBergen Drug Corp was awarded a delivery order valued at $32,675.40 by the Defense Logistics Agency on August 15, 2025, for the supply of Prevnar 20 vaccine in 0.5 mL syringe format. This is a firm fixed-price contract with an ultimate completion date of August 18, 2025, with no set-aside designation applied. The award represents a competitively-bid delivery order executed under the company's existing contract vehicle with DLA, reflecting the agency's continued reliance on AmerisourceBergen as a critical pharmaceutical supplier for federal medical procurement. Performance is based in Conshohocken, Pennsylvania, the company's corporate headquarters location. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The contract encompasses critical medical commodities including specialty medications, vaccines, syringes, and medical supplies across multiple therapeutic domains, supporting customers including the Defense Health Agency and U.S. Coast Guard. The Prevnar 20 award exemplifies the company's role in delivering essential immunological products to the defense health system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $32.7k | 8/15/25 |